Page last updated: 2024-08-22

cladribine and Necrosis

cladribine has been researched along with Necrosis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cros, E; Dumontet, C; Falette, N; Galmarini, CM; Jordheim, L; Puisieux, A; Voorzanger, N1
Hershko, C; Rosenmann, E; Zevin, S1
Guchelaar, HJ; Haanen, C; Koopmans, RP; Reutelingsperger, CP; Vermes, I1

Other Studies

3 other study(ies) available for cladribine and Necrosis

ArticleYear
Influence of p53 and p21(WAF1) expression on sensitivity of cancer cells to cladribine.
    Biochemical pharmacology, 2003, Jan-01, Volume: 65, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Blotting, Northern; Blotting, Western; Cell Cycle; Cell Survival; Cladribine; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; Drug Screening Assays, Antitumor; Gene Expression; Humans; Necrosis; Reverse Transcriptase Polymerase Chain Reaction; Tumor Cells, Cultured; Tumor Suppressor Protein p53

2003
Halogenoderma of the forearm caused by 2-chlorodeoxyadenosine treatment.
    American journal of hematology, 1996, Volume: 53, Issue:3

    Topics: Adult; Antimetabolites, Antineoplastic; Chlorine; Cladribine; Drug Eruptions; Forearm; Humans; Hyperplasia; Infusions, Intravenous; Leukemia, Hairy Cell; Male; Necrosis; Skin

1996
Apoptosis- and necrosis-inducing potential of cladribine, cytarabine, cisplatin, and 5-fluorouracil in vitro: a quantitative pharmacodynamic model.
    Cancer chemotherapy and pharmacology, 1998, Volume: 42, Issue:1

    Topics: Antineoplastic Agents; Apoptosis; Cisplatin; Cladribine; Combined Modality Therapy; Cytarabine; Dose-Response Relationship, Drug; Flow Cytometry; Fluorouracil; Humans; Jurkat Cells; Models, Theoretical; Necrosis; Radiotherapy; Tumor Cells, Cultured

1998